their chinese sites are working now but were down a few days ago too i noticed. no new news on their chinese sites of late.. but lots of news otherwise in their ling feng plant including a visit from a Harvard delegation that Lily is part of.
OTC .. just a few market makers that don't look at each other. Etrade and Stewart .. not sure but call OTC and ask who makes market then call your broker to move trade to another desk.
TCM stocks doing well in China ..
currency 6.21 now..
was checking news on the brokade website .. gxbk .. found this piece from January 24th:
" On January 24, Ms. Nguyen Thi Park, Chairman of the Board of the Socialist Republic of Vietnam the Asian Pharmaceutical Trade AG, General Manager, shareholders Mr. Nguyen marine, Miss Su Heng, deputy general manager responsible for foreign business, product registration section of Ms. Chen Cuiqin well Clerk Ms. Nguyen's hanging Zhuang his five under accompanied in the AOBO deputy general manager of the eastern United States, Hong Kong Branch Zhangzhi Mr. Fang, visit the Brocade Pharmaceutical discuss trade cooperation matters. Executive Director of the Company, Mr. Zhang Hanhe (also served as the executive director of the Lingfeng Pharmaceutical), Deputy General Manager and Chief Financial Officer Niesi Jun President, vice president and product development director of the Center for Ruanbi Fang representatives meeting in the office building on the third floor of the Brocade Pharmaceutical chamber commerce cooperation with the Vietnamese guests a cordial and friendly conversation.
The Vietnam Asia Pharmaceutical Trade AG second visit the Brocade Pharmaceutical. More than a year ago, the company had sent a high-level delegation to the Brocade the Pharmaceutical-site visits and business co-operation negotiations, frank conversation with the joint efforts of the two sides are already reached a preliminary cooperation intention. The Vietnamese guests early on Brocade Pharmaceutical production, specializing in the treatment of rhinitis Chinese brand products, Guangxi famous trademark "title Brocade brand rhinitis water well Lingfeng Pharmaceutical specialized branded products for the treatment of gynecological diseases ---- Golden Rooster capsule showed a keen interest in, one of the main purpose of the visit the Brocade medicine is to discuss how these two brand products as soon as possible the introduction of Vietnam and the Vietnamese people the benefit of the.
In SEC filings, a correspondence with the SEC throughout 2012, Lily responded on March 29th about a question relating to the money owed to AOB via the third party for that subsidiary they sold ...
March 29, 2012
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-4628
Attn: Tabatha Aikin, Senior Assistant Chief Accountant
Re: American Oriental Bioengineering, Inc. Form 10-K for the Fiscal Year Ended December 31, 2010 Filed March 15, 2011 and Amended November 14, 2011 Form 10-Q for the Quarterly Period Ended September 30, 2011 Filed November 14, 2011 File No.
Dear Ms. Aikin:
We are responding to your comments over the phone as described by Hong Zhu, an employee of American Oriental Bioengineering, Inc. (“Company”), and the written version of the comments received on March 28, 2012. The numbered paragraphs set forth below correspond to the Staff’s comments in the previous round of written communications with Staff dated February 9, 2012.
Form 10-Q for the Period Ended September 30, 2011
Notes to Condensed Consolidated Financial Statements
Note 11 – Receivable for Disposal of Investment, page 19
1. Please refer to your response to our comment two. If such amount is not received by the date you file the Form 10-K for the fiscal year ended December 31, 2011, please confirm that you will disclose the $5m in cash consideration and the equity interest received, as well as the date you expect to receive the remaining amount from the buyer as well as a statement indicating why you believe the balance is still collectible.
As of the date of this response letter, the Company has received the full consideration for the transaction, consisting of $22.5 million cash consideration and the equity interests of another company owned by the third party buyer.
/s/ Yanchun Li
Chief Financial Officer
American Oriental Bioengineering
Add that $17.5 million!
we're now above the 200 day moving average for the fist time since mid 2009 when it peaked over it for a bit.
the 20 and 50 day moving average should cross over the 200 day soon as well...
technicals are at least improving.
don't know .. maybe we'll get 2012 results in March.
There was news out of china that they are going to make efforts to take down the number of drug wholesalers from 13,000 to 3,000 .. the drug stocks in China were up on that news at 18 month highs.